1. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial. Issue 10342 (11th June 2022) Authors: Li, Grace; Cappuccini, Federica; Marchevsky, Natalie G; Aley, Parvinder K; Aley, Robert; Anslow, Rachel; Bibi, Sagida; Cathie, Katrina; Clutterbuck, Elizabeth; Faust, Saul N; Feng, Shuo; Heath, Paul T; Kerridge, Simon; Lelliott, Alice; Mujadidi, Yama; Ng, Khuen Foong; Rhead, Sarah; Roberts, Hanna... Journal: Lancet Issue: Volume 399:Issue 10342(2022) Page Start: 2212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗